Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Prof Tony Attwood
Women and Autism
Dr Robert Hungerford
Cardiovascular Risk Assessment in Lipid Management
Dr Marita Long & Dr Talat Uppal
Q&A on Heavy Menstrual Bleeding Management
Prof Hubertus Jersmann
Spirometry for COPD - GP Guide
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
